Article
Molecular pathophysiology of myelodysplastic syndromes.
Annual review of pathology - 24 Jan 2013
Lindsley R Coleman, Ebert Benjamin L
Abstract excerpt
The clinicopathologic heterogeneity of myelodysplastic syndromes (MDS) is driven by diverse, somatically acquired genetic abnormalities. Recent technological advances have enabled the identification of many new mutations, which have implicated novel pathways in MDS pathogenesis, including RNA splicing and epigenetic regulation of gene expression. Molecular abnormalities, either somatic point mutations or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
